Erratum to: pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients

被引：0
|
作者：
Gabriele Buda
Enrico Orciuolo
Sara Galimberti
Matteo Pelosini
Mario Petrini
机构：
[1] Pisa University,Department of Oncology, Transplants and Advanced Technologies, Section of Hematology
来源：
Annals of Hematology | 2011年 / 90卷 / 7期
关键词：
D O I：
10.1007/s00277-011-1203-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：863 / 863
相关论文
共 50 条
  • [41] A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma
    Gabriel N. Waterman
    Ori Yellin
    Regina A. Swift
    Russell Mapes
    Benjamin Eades
    Emily Ackerman
    James R. Berenson
    [J]. Annals of Hematology, 2011, 90 : 193 - 200
  • [42] Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy
    Sonneveld, Pieter
    Hajek, Roman
    Nagler, Arnon
    Spencer, Andrew
    Blade, Joan
    Robak, Tadeusz
    Zhuang, Sen H.
    Harousseau, Jean-Luc
    Orlowski, Robert Z.
    [J]. CANCER, 2008, 112 (07) : 1529 - 1537
  • [43] Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Tiedemann, Rodger
    Kukreti, Vishal
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 555 - 560
  • [44] Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Sonneveld, Pieter
    Dimopoulos, Meletios A.
    Boccadoro, Mario
    Quach, Hang
    Ho, P. Joy
    Beksac, Meral
    Hulin, Cyrille
    Antonioli, Elisabetta
    Leleu, Xavier
    Mangiacavalli, Silvia
    Perrot, Aurore
    Cavo, Michele
    Belotti, Angelo
    Broijl, Annemiek
    Gay, Francesca
    Mina, Roberto
    Nijhof, Inger S.
    van de Donk, Niels W. C. J.
    Katodritou, Eirini
    Schjesvold, Fredrik
    Sureda Balari, Anna
    Rosinol, Laura
    Delforge, Michel
    Roeloffzen, Wilfried
    Silzle, Tobias
    Vangsted, Annette
    Einsele, Hermann
    Spencer, Andrew
    Hajek, Roman
    Jurczyszyn, Artur
    Lonergan, Sarah
    Ahmadi, Tahamtan
    Liu, Yanfang
    Wang, Jianping
    Vieyra, Diego
    van Brummelen, Emilie M. J.
    Vanquickelberghe, Veronique
    Sitthi-Amorn, Anna
    de Boer, Carla J.
    Carson, Robin
    Rodriguez-Otero, Paula
    Blade, Joan
    Moreau, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (04): : 301 - 313
  • [45] Effect of the combination of pegylated liposomal doxorubicin and bortezomib on time to progression (TTP) and overall survival of patients with relapsed/refractory multiple myeloma compared with bortezomib alone
    Harousseau, J. L.
    Nagler, A.
    Sonneveld, P.
    Blade, J.
    Hajek, R.
    Spencer, A.
    Robak, T.
    Xiu, L.
    Zhuang, S. H.
    Orlowski, R. Z.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Pegylated Liposomal Doxorubicin in Salvage Chemotherapy for Multiple Myeloma Patients
    Romano, Alessandra
    Uccello, Giuseppina
    Spina, Paolo
    Cunsolo, Rosario
    Vetro, Calogero
    Di Raimondo, Francesco
    [J]. CURRENT CANCER THERAPY REVIEWS, 2013, 9 (01) : 1 - 7
  • [47] Modifications to therapy for multiple myeloma: Pegylated liposomal doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomide
    Hussein, MA
    [J]. ONCOLOGIST, 2003, 8 : 39 - 45
  • [48] Pre-clinical evaluation of bortezomib, doxorubicin, dexamethasone, and lenalidomide in multiple myeloma (MM)
    Hari, M.
    Hector-Word, Z.
    Lebovic, D.
    Soengas, M.
    Jakubowiak, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Bortezomib [VELCADE™], pegylated liposomal doxorubicin [DOXIL/CAELYX®] and dexamethasone in the treatment of previously untreated multiple myeloma patients:: Impact on quality-of-life
    Belch, Andrew
    Reece, Donna E.
    Bahlis, Nizar J.
    White, Darrell
    Teixeira, Bruno
    Camacho, Fernando
    Plante, Richard K.
    [J]. BLOOD, 2007, 110 (11) : 1058A - 1059A
  • [50] Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma
    Uttervall, Katarina
    Bruchfeld, Johanna Borg
    Gran, Charlotte
    Walinder, Goran
    Mansson, Robert
    Lund, Johan
    Gahrton, Gosta
    Alici, Evren
    Nahi, Hareth
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (03) : 247 - 254
12345